Market Access Fixing the inequity of drug access outside of the US In this new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes guest Cem Zorlular, CEO of Er-Kim Pharmaceuticals, for a conversation on antimicrobial r
Views & Analysis Combating antimicrobial resistance with a viable alternative... Antimicrobial resistance (AMR) is an issue of global concern, killing roughly 1.2 million1 people per year and projected to rise to
R&D Coalition issues rallying cry to takes the fight against AMR... Team up, wake up, and act before AMR turns back the clock on medical advances, say the cross-sector team behind the Infection Management Coalition.
News Agios shares slide as it abandons sickle cell candidate Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in sickle cell disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.